190 related articles for article (PubMed ID: 34185571)
1. Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline.
Vanderpuye VD; Clemenceau JRV; Temin S; Aziz Z; Burke WM; Cevallos NL; Chuang LT; Colgan TJ; Del Carmen MG; Fujiwara K; Kohn EC; Gonzáles Nogales JE; Konney TO; Mukhopadhyay A; Paudel BD; Tóth I; Wilailak S; Ghebre RG
JCO Glob Oncol; 2021 Jun; 7():1032-1066. PubMed ID: 34185571
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline.
Costas-Chavarri A; Nandakumar G; Temin S; Lopes G; Cervantes A; Cruz Correa M; Engineer R; Hamashima C; Ho GF; Huitzil FD; Malekzadeh Moghani M; Sharara AI; Stern MC; Teh C; Vázquez Manjarrez SE; Verjee A; Yantiss R; Shah MA
J Glob Oncol; 2019 Feb; 5():1-19. PubMed ID: 30802158
[TBL] [Abstract][Full Text] [Related]
3. Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline.
Al Sukhun S; Temin S; Barrios CH; Antone NZ; Guerra YC; Chavez-MacGregor M; Chopra R; Danso MA; Gomez HL; Homian NM; Kandil A; Kithaka B; Koczwara B; Moy B; Nakigudde G; Petracci FE; Rugo HS; El Saghir NS; Arun BK
JCO Glob Oncol; 2024 Jan; 10():e2300285. PubMed ID: 38206277
[TBL] [Abstract][Full Text] [Related]
4. Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline.
Chuang LT; Temin S; Camacho R; Dueñas-Gonzalez A; Feldman S; Gultekin M; Gupta V; Horton S; Jacob G; Kidd EA; Lishimpi K; Nakisige C; Nam JH; Ngan HYS; Small W; Thomas G; Berek JS
J Glob Oncol; 2016 Oct; 2(5):311-340. PubMed ID: 28717717
[TBL] [Abstract][Full Text] [Related]
5. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.
Jeronimo J; Castle PE; Temin S; Denny L; Gupta V; Kim JJ; Luciani S; Murokora D; Ngoma T; Qiao Y; Quinn M; Sankaranarayanan R; Sasieni P; Schmeler KM; Shastri SS
J Glob Oncol; 2017 Oct; 3(5):635-657. PubMed ID: 29094101
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline.
Chiorean EG; Nandakumar G; Fadelu T; Temin S; Alarcon-Rozas AE; Bejarano S; Croitoru AE; Grover S; Lohar PV; Odhiambo A; Park SH; Garcia ER; Teh C; Rose A; Zaki B; Chamberlin MD
JCO Glob Oncol; 2020 Mar; 6():414-438. PubMed ID: 32150483
[TBL] [Abstract][Full Text] [Related]
7. Palliative Care in the Global Setting: ASCO Resource-Stratified Practice Guideline.
Osman H; Shrestha S; Temin S; Ali ZV; Corvera RA; Ddungu HD; De Lima L; Del Pilar Estevez-Diz M; Ferris FD; Gafer N; Gupta HK; Horton S; Jacob G; Jia R; Lu FL; Mosoiu D; Puchalski C; Seigel C; Soyannwo O; Cleary JF
J Glob Oncol; 2018 Jul; 4():1-24. PubMed ID: 30085844
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Wright AA; Bohlke K; Armstrong DK; Bookman MA; Cliby WA; Coleman RL; Dizon DS; Kash JJ; Meyer LA; Moore KN; Olawaiye AB; Oldham J; Salani R; Sparacio D; Tew WP; Vergote I; Edelson MI
Gynecol Oncol; 2016 Oct; 143(1):3-15. PubMed ID: 27650684
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Wright AA; Bohlke K; Armstrong DK; Bookman MA; Cliby WA; Coleman RL; Dizon DS; Kash JJ; Meyer LA; Moore KN; Olawaiye AB; Oldham J; Salani R; Sparacio D; Tew WP; Vergote I; Edelson MI
J Clin Oncol; 2016 Oct; 34(28):3460-73. PubMed ID: 27502591
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic and prognostic value of tumor markers, scores (clinical and biological) algorithms, in front of an ovarian mass suspected of an epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Bendifallah S; Body G; Daraï E; Ouldamer L
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):134-154. PubMed ID: 30733191
[TBL] [Abstract][Full Text] [Related]
11. [Progress in preoperative evaluation methods regarding cytoreduction in patients with advanced ovarian cancer].
Liu J; Zhang K
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 42(7):854-859. PubMed ID: 28845013
[TBL] [Abstract][Full Text] [Related]
12. To compare the optimal cytoreduction rate in advanced epithelial ovarian cancer stage III/IV after 3 versus 6 cycles of neoadjuvant chemotherapy.
Kumari A; Thakur M; Saha SC; Suri V; Prasad GRV; Patel FD; Radhika S
J Obstet Gynaecol; 2021 May; 41(4):616-620. PubMed ID: 32811236
[TBL] [Abstract][Full Text] [Related]
13. A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.
Morimoto A; Nagao S; Kogiku A; Yamamoto K; Miwa M; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Fujiwara K
Jpn J Clin Oncol; 2016 Jun; 46(6):517-21. PubMed ID: 26977055
[TBL] [Abstract][Full Text] [Related]
14. Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline.
Arrossi S; Temin S; Garland S; Eckert LO; Bhatla N; Castellsagué X; Alkaff SE; Felder T; Hammouda D; Konno R; Lopes G; Mugisha E; Murillo R; Scarinci IC; Stanley M; Tsu V; Wheeler CM; Adewole IF; de Sanjosé S
J Glob Oncol; 2017 Oct; 3(5):611-634. PubMed ID: 29094100
[TBL] [Abstract][Full Text] [Related]
15. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline Update.
Shastri SS; Temin S; Almonte M; Basu P; Campos NG; Gravitt PE; Gupta V; Lombe DC; Murillo R; Nakisige C; Ogilvie G; Pinder LF; Poli UR; Qiao Y; Woo YL; Jeronimo J
JCO Glob Oncol; 2022 Sep; 8():e2200217. PubMed ID: 36162041
[TBL] [Abstract][Full Text] [Related]
16. Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
Salvador S; Scott S; Glanc P; Eiriksson L; Jang JH; Sebastianelli A; Dean E
J Obstet Gynaecol Can; 2020 Aug; 42(8):1021-1029.e3. PubMed ID: 32736853
[TBL] [Abstract][Full Text] [Related]
17. [Surgery for advanced stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Ferron G; Narducci F; Pouget N; Touboul C
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):197-213. PubMed ID: 30792175
[TBL] [Abstract][Full Text] [Related]
18. Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol.
Li S; Bercow AS; Falzone M; Kalyanaraman R; Worley MJ; Feltmate CM; Pelletier A; Elias KM
Gynecol Oncol; 2021 Aug; 162(2):353-359. PubMed ID: 34092412
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
[TBL] [Abstract][Full Text] [Related]
20. Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Morgan RD; McNeish IA; Cook AD; James EC; Lord R; Dark G; Glasspool RM; Krell J; Parkinson C; Poole CJ; Hall M; Gallardo-Rincón D; Lockley M; Essapen S; Summers J; Anand A; Zachariah A; Williams S; Jones R; Scatchard K; Walther A; Kim JW; Sundar S; Jayson GC; Ledermann JA; Clamp AR
Lancet Oncol; 2021 Feb; 22(2):277-288. PubMed ID: 33357510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
